CAS: 610798-31-7 - Icotinib
Formula:C22H21N3O4
InChI:InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-22-18-13-20-21(14-19(18)23-15-24-22)29-11-9-27-7-6-26-8-10-28-20/h1,3-5,12-15H,6-11H2,(H,23,24,25)
InChI key:InChIKey=QQLKULDARVNMAL-UHFFFAOYSA-N
SMILES:C#CC1=CC=CC(=C1)NC=2N=CN=C3C=C4OCCOCCOCCOC4=CC32
- Synonyms:
- Bpi 2009H
- Icotinib int. N-1
- N-(3-Ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine
- [1,4,7,10]Tetraoxacyclododecino[2,3-g]quinazolin-4-amine, N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Icotinib Hydrochloride REF: 4Z-I-136001CAS: | - - - | To inquire | Tue 17 Dec 24 | |
Icotinib REF: TM-T6153CAS: 610798-31-7 | 100% | 48.00 €~700.00 € | Tue 14 Jan 25 | |
4-(3-Ethynylphenyl)amino)-6,7-benzo-12-crown-4-quinazoline REF: 3D-FE146411CAS: 610798-31-7 | Min. 95% | To inquire | Tue 21 Jan 25 |
Ref: 4Z-I-136001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Icotinib
CAS:610798-31-7
Icotinib (Conmana) is an orally available quinazoline-based inhibitor of epidermal growth factor receptor (EGFR), with …
Formula:
C22H21N3O4
Purity:
100%
Color and Shape:
Solid
Molecular weight:
391.42
Ref: TM-T6153
1mg | 48.00 € | ||
2mg | 63.00 € | ||
5mg | 94.00 € | ||
10mg | 152.00 € | ||
25mg | 276.00 € | ||
50mg | 518.00 € | ||
100mg | 700.00 € | ||
1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
4-(3-Ethynylphenyl)amino)-6,7-benzo-12-crown-4-quinazoline
CAS:610798-31-7
4-(3-Ethynylphenyl)amino)-6,7-benzo-12-crown-4-quinazoline is a topoisomerase inhibitor that has been shown to inhibit the proliferation of cancer …
Purity:
Min. 95%
Ref: 3D-FE146411
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025